What is NTHI's intangible assets non current?

NTHI (NTHI) reported intangible assets non current of $488.43K in Q1 2026.

What does intangible assets non current mean?

This represents the carrying value of non-physical assets such as patents, intellectual property, and licenses that provide long-term economic benefits. For a biotechnology company, this is a critical indicator of the value of proprietary drug delivery technologies and clinical pipelines. It reflects the company's investment in future competitive advantages.

NTHI NTHI Intangible Assets Non Current

Intangible Assets Non Current at other companies

AmgenAMGN

$20.67B-16.2%

Natera, Inc.NTRA

$367.36M—

MSCIMSCI

$851M-4.0%

Monolithic Power SystemsMPWR

$8.5M-11.9%

Becton, Dickinson and CompanyBDX

$450M-15.1%

General DynamicsGD

$1.33B-9.2%

Other financials

Income statement

See full

Revenue$40.0K-7.0%

Operating income-$7.1M+77.9%

Net income-$8.8M+72.7%

EPS (diluted)-$0.38+78.7%

Balance sheet

See full

Cash & equivalents$138.6K-97.5%

Total debt$666.1K—

Total equity-$13.2M-37.5%

Total assets$3.3M-60.6%

Cash flow

See full

Operating cash flow-$7.0M-23.7%

CapEx$125.0K—

Free cash flow-$5.2M—

Valuation

See full

Market cap$114.62M+51.0%

Enterprise value$115.15M+51.1%

P/S1,432.9×—

Profitability

See full

Operating margin-46,870.7%—

Net margin-51,613.3%—

FCF margin-26,083.2%—

Returns & leverage

See full

Return on equity338.1%—

Debt / equity-0.1×—

Current ratio0.1×-0.3×

Where this comes from

Reported directly by NTHI in its filing.

Tagged under the XBRL concept nthi:IntangibleAssetsNonCurrent.

The official record: NTHI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's intangible assets non current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NTHI's intangible assets non current?: NTHI (NTHI) reported intangible assets non current of $488.43K in Q1 2026.
What does intangible assets non current mean?: This represents the carrying value of non-physical assets such as patents, intellectual property, and licenses that provide long-term economic benefits. For a biotechnology company, this is a critical indicator of the value of proprietary drug delivery technologies and clinical pipelines. It reflects the company's investment in future competitive advantages.